ACTIVE SUBSTANCE / INN

PERTUZUMAB

Brand name(s): Perjeta, PERJETA, Poherdy
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
OPINION
Breast Neoplasms
BLA125409
ACTIVE SUBSTANCE
Pertuzumab
REGULATORS
FDA · EMA
SPONSORS / MAH
GENENTECH, Roche Registration GmbH , Organon N.V.
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PERJETABLA125409GENENTECHPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PoherdyOrganon N.V.OpinionBreast Neoplasms
PerjetaRoche Registration GmbH Authorised04/03/2013Breast Neoplasms

FULL INTELLIGENCE ON PERTUZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →